Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
One Percent Rule Checklist For Safer Forex Trading Risk 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
NEW YORK, April 18, 2017 -- Safirstein Metcalf LLP announces that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of all persons or entities who purchased or otherwise acquired securities of Adeptus Health, Inc. ("Adeptus Health”) (NASDAQ:ADPT) between April 29, 2016 and March 1, 2017.
If you purchased Adeptus Health securities during the Class Period, and would like more information about getting involved in the Adeptus Health Shareholder Class Action, please call 1-800-221-0015, or email [email protected]. If you wish to serve as lead plaintiff, you must move the Court no later than May 9, 2017.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
| Company: | Adeptus Health, Inc. | |||
| Exchange: | NASDAQ | |||
| Ticker: | ADPT | |||
| Class Period: | 4/29/16 – 3/1/17 | |||
| Lead Plaintiff Date: | 5/9/17 |
The complaint alleges that throughout the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, Defendants' statements about Adeptus' business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
According to the complaint, following a March 2, 2017 filing of a Form 12b-25 announcing the delay in the filing of its Form 10-K and revealing weaknesses in internal controls, the value of Adeptus shares declined more than 50% to close at $2.79 on March 2, 2017.
About Safirstein Metcalf LLP
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP Peter Safirstein, Esq. 1250 Broadway 27th Floor New York, NY 10001 1-800-221-0015
